Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20.
Article
Google Scholar
Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212–24.
Article
CAS
Google Scholar
Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69(4):896–904.
Article
Google Scholar
Estes C, Chan HLY, Chien RN, et al. Modelling NAFLD disease burden in four Asian regions-2019-2030. Aliment Pharmacol Ther. 2020;51(8):801–11.
Article
CAS
Google Scholar
Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223–38.
Article
Google Scholar
Paik JM, Golabi P, Younossi Y, Srishord M, Mishra A, Younossi ZM. The growing burden of disability related to nonalcoholic fatty liver disease: data from the global burden of disease 2007–2017. Hepatol Commun. 2020;4(12):1769–80.
Article
Google Scholar
Tan DJH, Ng CH, Lin SY, et al. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. Lancet Oncol. 2022;23(4):521–30.
Article
Google Scholar
Younossi Z, Tacke F, Arrese M, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69(6):2672–82.
Article
Google Scholar
Younossi ZM, Stepanova M, Younossi Y, et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 2020;69(3):564–8.
Article
Google Scholar
Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377(21):2063–72.
Article
CAS
Google Scholar
Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612.
Article
Google Scholar
Wong SW, Ting YW, Chan WK. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications. JGH Open. 2018;2(5):235–41.
Article
Google Scholar
Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793–801.
Article
Google Scholar
Yang JD, Mohamed HA, Cvinar JL, Gores GJ, Roberts LR, Kim WR. Diabetes mellitus heightens the risk of hepatocellular carcinoma except in patients with hepatitis C cirrhosis. Am J Gastroenterol. 2016;111(11):1573–80.
Article
CAS
Google Scholar
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–45.
Article
CAS
Google Scholar
Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW. Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016;65(8):1096–108.
Article
CAS
Google Scholar
Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674–83.
Article
Google Scholar
Collaborators GBDA. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet. 2022;400(10347):185–235.
Article
Google Scholar
Collaborators GBDRF. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–1249.
Collaborators GBDD. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1160–203.
Article
Google Scholar
Collaborators GBDUHC. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1250–1284.
Collaborators GBDCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788.
Ghamari SH, Yoosefi M, Abbasi-Kangevari M, et al. Trends in global, regional, and national burden and quality of care index for liver cancer by cause from global burden of Disease 1990–2019. Hepatol Commun. 2022;6(7):1764–75.
Article
Google Scholar
Liu Y, Zheng J, Hao J, et al. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019. Cancer Med. 2022;11(5):1310–23.
Article
CAS
Google Scholar
Liang R, Feng X, Shi D, et al. The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990–2019: An updated analysis for the Global Burden of Disease Study 2019. Diabetes Metab Res Rev. 2022;56:e3572.
Google Scholar
Hung GY, Horng JL, Yen HJ, Lee CY, Lin LY. Changing incidence patterns of hepatocellular carcinoma among age groups in Taiwan. J Hepatol. 2015;63(6):1390–6.
Article
Google Scholar
Li X, Cao X, Guo M, Xie M, Liu X. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ. 2020;368: m234.
Article
Google Scholar
Guerrero-Velasco R, Munoz VH, Concha-Eastman A, Pretel-Meneses AJ, Gutierrez-Martinez MI, Santaella-Tenorio J. Homicide Epidemic in Cali, Colombia: A Surveillance System Data Analysis, 19932018. Am J Public Health. 2021;111(7):1292–9.
Article
Google Scholar
Xing QQ, Li JM, Dong X, et al. Socioeconomics and attributable etiology of primary liver cancer, 1990–2019. World J Gastroenterol. 2022;28(21):2361–82.
Article
Google Scholar
Li C, He WQ. Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory. Liver Int. 2022;42(10):2299–316.
Article
Google Scholar
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.
Article
Google Scholar
Berkan-Kawinska A, Piekarska A. Hepatocellular carcinoma in non-alcohol fatty liver disease - changing trends and specific challenges. Curr Med Res Opin. 2020;36(2):235–43.
Article
Google Scholar
Sanyal AJ, Harrison SA, Ratziu V, et al. The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials. Hepatology. 2019;70(6):1913–27.
Article
CAS
Google Scholar
Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol. 2017;23(47):8263–76.
Article
Google Scholar
Sumida Y, Yoneda M. Current and future pharmacological therapies for NAFLD/NASH. J Gastroenterol. 2018;53(3):362–76.
Article
CAS
Google Scholar
Stine JG, Wentworth BJ, Zimmet A, et al. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases. Aliment Pharmacol Ther. 2018;48(7):696–703.
Article
Google Scholar
Gastaldelli A, Cusi K. From NASH to diabetes and from diabetes to NASH: mechanisms and treatment options. JHEP Rep. 2019;1(4):312–28.
Article
Google Scholar
Luukkonen PK, Sadevirta S, Zhou Y, et al. Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars. Diabetes Care. 2018;41(8):1732–9.
Article
CAS
Google Scholar
Zou Y, Yu M, Sheng G. Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study. Lipids Health Dis. 2020;19(1):145.
Article
CAS
Google Scholar
Bertot LC, Jeffrey GP, de Boer B, et al. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease. Liver Int. 2018;38(10):1793–802.
Article
CAS
Google Scholar
Xue Y, Zhou J, Wang P, et al. Burden of tuberculosis and its association with socio-economic development status in 204 countries and territories, 1990–2019. Front Med (Lausanne). 2022;9: 905245.
Article
Google Scholar
Zeng DY, Li JM, Lin S, et al. Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990–2019. J Hepatol. 2021;75(3):547–56.
Article
Google Scholar
Safiri S, Nejadghaderi SA, Karamzad N, et al. Global, regional and national burden of cancers attributable to high fasting plasma glucose in 204 countries and territories, 1990–2019. Front Endocrinol (Lausanne). 2022;13: 879890.
Article
Google Scholar
Ye L, Xu J, Zhang T, et al. Global burden of noncommunicable diseases attributable to high fasting plasma glucose. J Diabetes. 2020;12(11):807–18.
Article
Google Scholar
Martinez-Garcia M, Gutierrez-Esparza GO, Roblero-Godinez JC, et al. Cardiovascular risk factors and social development index. Front Cardiovasc Med. 2021;8: 631747.
Article
CAS
Google Scholar
Katikireddi SV, Skivington K, Leyland AH, Hunt K, Mercer SW. The contribution of risk factors to socioeconomic inequalities in multimorbidity across the lifecourse: a longitudinal analysis of the Twenty-07 cohort. BMC Med. 2017;15(1):152.
Article
Google Scholar
Collaborators GBDDitA. Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Diabetes Endocrinol. 2022;10(9):655–667.
Liu J, Bai R, Chai Z, Cooper ME, Zimmet PZ, Zhang L. Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990–2019 data. Diabetologia. 2022;65(8):1339–52.
Article
Google Scholar
Dong B, Zou Z, Song Y, et al. Adolescent Health and Healthy China 2030: A Review. J Adolesc Health. 2020;67(5S):S24–31.
Article
Google Scholar
Ye F, Zhai M, Long J, et al. The burden of liver cirrhosis in mortality: results from the global burden of disease study. Front Public Health. 2022;10: 909455.
Article
Google Scholar